Document 0892
 DOCN  M9550892
 TI    Mononuclear cell adoptive immunotherapy.
 DT    9505
 AU    Lee JH; Klein HG; Department of Transfusion Medicine, Warren G. Magnuson
       Clinical; Center, National Institutes of Health, Bethesda, Maryland.
 SO    Hematol Oncol Clin North Am. 1994 Dec;8(6):1203-21. Unique Identifier :
       AIDSLINE MED/95164347
 AB    In contrast with red cells, platelets, and granulocytes, hemotherapy
       using lymphocytes and monocytes is only beginning to be explored. Blood
       banks and transfusion services, the traditional sources of expertise in
       sterile cell processing, storage, and transfusion, have played an
       integral role in the early technical development of mononuclear cell
       adoptive immunotherapy, and are logical partners in its future. This
       article reviews the clinical experience with this novel transfusion
       therapy.
 DE    Abortion, Habitual/THERAPY  Diabetes Mellitus, Insulin-Dependent/THERAPY
       Female  Graft vs Host Reaction  Herpesvirus 4, Human  Human  HIV
       Infections/THERAPY  *Immunotherapy, Adoptive  Killer Cells,
       Lymphokine-Activated  Leukemia/THERAPY  *Leukocytes, Mononuclear
       Lymphocytes, Tumor-Infiltrating  Lymphoproliferative
       Disorders/THERAPY/VIROLOGY  Pregnancy  JOURNAL ARTICLE  REVIEW  REVIEW,
       TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).